Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Andrew Baker
GS
Andrew Baker
Goldman Sachs
Wall Street Analyst
Not yet ranked — too few measurable calls.
100%
Success Rate
+37.1%
Average Return
2 of 2 calls profitable · +13.8% vs benchmark
📈 Across the calls we could measure, roughly 100% of Andrew Baker's ratings turned a profit when each position was held for 1 year — averaging +37.1% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

26 Buy 28 Hold 7 Sell
Andrew's Stock Coverage 22 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
NL:NN
NN Group N.V.
 May 22, 2026 BUY Buy
-14.7% avg upside
11 analysts
$83.00
10.80% Upside
 ·
IT:G
Assicurazioni Generali S.p.A.
 May 22, 2026 HOLD Buy
-15.4% avg upside
15 analysts
$37.20
12.55% Downside
 ·
NL:ASRNL
ASR Nederland N.V
 May 22, 2026 BUY Strong Buy
+0.4% avg upside
9 analysts
$75.00
13.28% Upside
 ·
GB:0Q99
ageas NV
 May 22, 2026 HOLD Buy
-11.8% avg upside
7 analysts
$70.00
3.69% Upside
 ·
DE:MUV2
Munich Reinsurance
 May 13, 2026 HOLD Buy
-0.1% avg upside
14 analysts
$557.00
18.23% Upside
 ·
CH:SREN
Swiss Re AG
 May 13, 2026 SELL Buy
-2.2% avg upside
12 analysts
$114.00
7.54% Downside
 ·
GB:MNG
M&G Plc
 Apr 21, 2026 HOLD Buy
-10.2% avg upside
13 analysts
$320.00
3.42% Downside
 ·
DE:ALV
Allianz
 Apr 21, 2026 BUY Buy
-10.3% avg upside
21 analysts
$450.00
12.43% Upside
 ·
DE:HNR1
Hannover Rueck
 Mar 16, 2026 BUY Buy
+12.8% avg upside
13 analysts
$301.00
28.52% Upside
 ·
FR:CS
AXA SA
 Mar 03, 2026 BUY Strong Buy
+4.4% avg upside
17 analysts
$48.00
12.90% Upside
 ·
GB:SDLF
Standard Life plc
 Feb 05, 2026 HOLD Buy
-2.2% avg upside
12 analysts
$761.00
5.49% Downside
 ·
GB:ADM
Admiral
 Jan 21, 2026 SELL Hold
-9.0% avg upside
9 analysts
$2920.00
10.32% Downside
 ·
FR:SCR
SCOR
 Jan 21, 2026 HOLD Buy
-0.2% avg upside
9 analysts
$29.00
7.67% Downside
 ·
GB:LGEN
Legal & General
 Oct 17, 2025 HOLD Buy
+554.4% avg upside
15 analysts
$249.00
12.03% Downside
 ·
GB:AV
Aviva plc
 Sep 05, 2025 BUY Buy
+2.8% avg upside
14 analysts
 — ·
CH:ZURN
Zurich Insurance Group
 Aug 13, 2025 SELL Sell
+0.4% avg upside
14 analysts
$552.00
4.23% Downside
 ·
GB:HSX
Hiscox
 Jul 02, 2025 BUY Strong Buy
+490.5% avg upside
9 analysts
$1395.00
21.60% Downside
 ·
SCOR
comScore
 May 08, 2025 BUY Buy
+187.5% avg upside
12 analysts
 — +40.5%
GB:STJ
St. James's Place
 Feb 29, 2024 BUY Buy
+401.9% avg upside
16 analysts
$615.00
46.26% Downside
 ·
NL:AGN
Aegon NV
 Nov 17, 2023 HOLD Buy
-8.7% avg upside
11 analysts
$4.64
37.63% Downside
 ·
GB:PRU
Prudential
 Nov 07, 2023 BUY Strong Buy
+859.9% avg upside
22 analysts
$1256.57
24.88% Upside
 ·
AEG
Aegon
 Dec 11, 2020 HOLD Buy
-42.2% avg upside
7 analysts
 — +33.7%
🔒 17 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Andrew Baker — Frequently Asked Questions
How accurate are Andrew Baker's stock ratings?
Based on the calls 13Foresight could measure, about 100% of Andrew's ratings were profitable over a one-year hold, with an average return of +37.1% per rating, or +6.1% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Andrew ranked on 13Foresight?
Andrew Baker is currently ranked unranked . Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Andrew cover?
Andrew most recently has ratings on NL:NN, IT:G, NL:ASRNL, GB:0Q99, DE:MUV2, CH:SREN, GB:MNG, DE:ALV, DE:HNR1, FR:CS, GB:SDLF, GB:ADM and 10 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.